Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
109230979 | 10923097 | 9 | F | 20100303 | 20160915 | 20150317 | 20160920 | EXP | PHHY2010CA15776 | NOVARTIS | 55.90 | YR | M | Y | 100.00000 | KG | 20160920 | OT | CA | CA |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
109230979 | 10923097 | 1 | PS | SANDOSTATIN LAR DEPOT | OCTREOTIDE ACETATE | 1 | Intramuscular | 40 MG, EVERY 4 WEEKS | U | S0092 | 21008 | 40 | MG | /month | |||||
109230979 | 10923097 | 2 | SS | SANDOSTATIN LAR DEPOT | OCTREOTIDE ACETATE | 1 | Intramuscular | 30 MG, EVERY 28 DAYS | U | 21008 | 30 | MG | /month | ||||||
109230979 | 10923097 | 3 | SS | SANDOSTATIN LAR DEPOT | OCTREOTIDE ACETATE | 1 | Intramuscular | 30 MG, EVERY 3 WEEKS | U | 21008 | 30 | MG | |||||||
109230979 | 10923097 | 4 | SS | SANDOSTATIN LAR DEPOT | OCTREOTIDE ACETATE | 1 | Intramuscular | 30 MG, QMO (EVERY 4 WEEKS) | U | S0058 | 21008 | 30 | MG | /month | |||||
109230979 | 10923097 | 5 | C | ALTACE | RAMIPRIL | 1 | Unknown | QD (DAILY) | U | 0 | QD | ||||||||
109230979 | 10923097 | 6 | C | ASA | ASPIRIN | 1 | Unknown | 80 MG, QD | U | 0 | 80 | MG | QD | ||||||
109230979 | 10923097 | 7 | C | LANTUS | INSULIN GLARGINE | 1 | Unknown | QD (DAILY) | U | 0 | INJECTION | QD | |||||||
109230979 | 10923097 | 8 | C | HUMULIN R | INSULIN HUMAN | 1 | Unknown | BID | U | 0 | INJECTION | BID | |||||||
109230979 | 10923097 | 9 | C | CRESTOR | ROSUVASTATIN CALCIUM | 1 | Unknown | QD (DAILY) | U | 0 | QD |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
109230979 | 10923097 | 1 | Carcinoid tumour |
109230979 | 10923097 | 5 | Product used for unknown indication |
109230979 | 10923097 | 6 | Product used for unknown indication |
109230979 | 10923097 | 7 | Product used for unknown indication |
109230979 | 10923097 | 8 | Product used for unknown indication |
109230979 | 10923097 | 9 | Product used for unknown indication |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
109230979 | 10923097 | OT |
109230979 | 10923097 | HO |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
109230979 | 10923097 | Bile duct obstruction | |
109230979 | 10923097 | Blood glucose decreased | |
109230979 | 10923097 | Blood pressure diastolic decreased | |
109230979 | 10923097 | Blood pressure fluctuation | |
109230979 | 10923097 | Blood pressure increased | |
109230979 | 10923097 | Blood pressure systolic increased | |
109230979 | 10923097 | Body temperature decreased | |
109230979 | 10923097 | Chills | |
109230979 | 10923097 | Diabetes mellitus | |
109230979 | 10923097 | Discomfort | |
109230979 | 10923097 | Heart rate decreased | |
109230979 | 10923097 | Inappropriate schedule of drug administration | |
109230979 | 10923097 | Incorrect dose administered | |
109230979 | 10923097 | Jaundice | |
109230979 | 10923097 | Needle issue | |
109230979 | 10923097 | Ocular icterus | |
109230979 | 10923097 | Orthostatic hypotension | |
109230979 | 10923097 | Pain | |
109230979 | 10923097 | Post procedural complication | |
109230979 | 10923097 | Tremor | |
109230979 | 10923097 | Underdose | |
109230979 | 10923097 | Weight decreased | |
109230979 | 10923097 | Yellow skin |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
109230979 | 10923097 | 1 | 20060710 | 0 |